Posted inCardiology, Clinical Trials, In the Pipeline, Metabolism Enlicitide: Very Strong Pill Against ‘Bad’ Cholesterol February 27, 2024April 19, 2024 The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.
